Skip to main content
Livermore
Livermore
ZHEN

Neurogene Inc.

NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404644

In the last 90 days, Neurogene Inc. insiders filed 0 open-market purchases and 2 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Neurogene Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
35
+4 vs. Q3 2023
Shares held
9.23M
+8.32M (+912.1%) vs. Q3 2023Converted for a 1-for-4 split
Total value
$179.0M
+$164.5M (+1,141.4%) vs. Q3 2023
New holders
14
7 more added
Sold out
10
6 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NGNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 35 institutions
Q1 2021: 82 institutionsQ2 2021: 82 institutionsQ3 2021: 85 institutionsQ4 2021: 80 institutionsQ1 2022: 81 institutionsQ2 2022: 64 institutionsQ3 2022: 52 institutionsQ4 2022: 46 institutionsQ1 2023: 39 institutionsQ2 2023: 36 institutionsQ3 2023: 31 institutionsQ4 2023: 35 institutionsQ1 2024: 60 institutionsQ2 2024: 66 institutionsQ3 2024: 86 institutionsQ4 2024: 89 institutionsQ1 2025: 86 institutionsQ2 2025: 83 institutionsQ3 2025: 88 institutionsQ4 2025: 93 institutionsQ1 2026: 96 institutionsQ2 2026: 111 institutions
Value heldQ4 2023: $179.0M
Q1 2021: $341.9MQ2 2021: $248.8MQ3 2021: $187.1MQ4 2021: $118.8MQ1 2022: $46.3MQ2 2022: $21.4MQ3 2022: $12.0MQ4 2022: $8.66MQ1 2023: $10.5MQ2 2023: $14.3MQ3 2023: $14.4MQ4 2023: $179.0MQ1 2024: $617.3MQ2 2024: $482.7MQ3 2024: $581.1MQ4 2024: $367.8MQ1 2025: $192.8MQ2 2025: $230.1MQ3 2025: $265.2MQ4 2025: $340.4MQ1 2026: $342.0MQ2 2026: $544.4M
Institutions holding NGNE and their total value by quarter
QuarterHoldersValue
Q2 2026111$544.4M
Q1 202696$342.0M
Q4 202593$340.4M
Q3 202588$265.2M
Q2 202583$230.1M
Q1 202586$192.8M
Q4 202489$367.8M
Q3 202486$581.1M
Q2 202466$482.7M
Q1 202460$617.3M
Q4 202335$179.0M
Q3 202331$14.4M
Q2 202336$14.3M
Q1 202339$10.5M
Q4 202246$8.66M
Q3 202252$12.0M
Q2 202264$21.4M
Q1 202281$46.3M
Q4 202180$118.8M
Q3 202185$187.1M
Q2 202182$248.8M
Q1 202182$341.9M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Neurogene Inc.; share changes are against Q3 2023.

Institutions holding NGNE in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
National Bank of Canada8$1580.00%−1−8.6%ReducedConverted for a 1-for-4 split
JPMorgan Chase & Co10$1940.00%−1−11.1%ReducedConverted for a 1-for-4 split
Advisor Group Holdings, Inc.25$4850.00%00.0%UnchangedConverted for a 1-for-4 split
Truvestments Capital LLC46$8910.00%−0−0.5%ReducedConverted for a 1-for-4 split
Farther Finance Advisors, LLC50$9690.00%00.0%UnchangedConverted for a 1-for-4 split
Group One Trading, L.P.74$1.43K0.00%−1−1.0%ReducedConverted for a 1-for-4 split
Royal Bank of Canada104$2.00K0.00%+104New
Wells Fargo & Company414$8.02K0.00%00.0%UnchangedConverted for a 1-for-4 split
UBS Group AG1,000$19.4K0.00%+942+1,631.6%AddedConverted for a 1-for-4 split
US Bancorp3,467$67.2K0.00%00.0%UnchangedConverted for a 1-for-4 split
ADAR1 Capital Management, LLC5,405$104.7K0.05%+5,405New
Geode Capital Management, LLC15,719$304.7K0.00%00.0%UnchangedConverted for a 1-for-4 split
Bessemer Group Inc20,000$388.0K0.00%+20,000New
ExodusPoint Capital Management, LP20,306$394.0K0.00%+20,306New
BlackRock Inc.24,151$468.0K0.00%00.0%UnchangedConverted for a 1-for-4 split
BML Capital Management, LLC24,666$478.0K0.38%00.0%UnchangedConverted for a 1-for-4 split
Bank of America Corp49,729$963.7K0.00%−8,216−14.2%ReducedConverted for a 1-for-4 split
Renaissance Technologies LLC50,194$973.0K0.00%+9,332+22.8%AddedConverted for a 1-for-4 split
Vanguard Group Inc50,421$977.2K0.00%00.0%UnchangedConverted for a 1-for-4 split
Altium Capital Management LP66,981$1.30M0.89%+66,981New
Nantahala Capital Management, LLC72,279$1.40M0.14%−2,721−3.6%ReducedConverted for a 1-for-4 split
CVI Holdings, LLC126,725$2.46M5.08%+120,496+1,934.4%AddedConverted for a 1-for-4 split
Adage Capital Partners GP, L.L.C.135,581$2.63M0.01%+58,081+74.9%AddedConverted for a 1-for-4 split
Walleye Capital LLC188,501$3.65M0.05%+188,501New
Morgan Stanley339,979$6.59M0.00%+313,061+1,163.0%AddedConverted for a 1-for-4 split
Baker Bros. Advisors LP453,516$8.79M0.10%+148,163+48.5%AddedConverted for a 1-for-4 split
Avidity Partners Management LP466,243$9.04M0.35%+466,243New
Casdin Capital, LLC524,616$10.2M1.00%+524,616New
ArrowMark Colorado Holdings LLC525,529$10.2M0.11%+525,529New
Cormorant Asset Management, LP746,180$14.5M0.69%+746,180New
Janus Henderson Group PLC841,688$16.3M0.01%+841,688New
Redmile Group, LLC946,897$18.4M0.66%+801,286+550.3%AddedConverted for a 1-for-4 split
Great Point Partners LLC994,229$19.3M3.28%+994,229New
Samsara BioCapital, LLC1,267,790$24.6M3.82%+1,267,790New
EcoR1 Capital, LLC1,271,342$24.6M0.64%+1,271,342New
Millennium Management LLC0$00.00%−9,439−100.0%Sold outConverted for a 1-for-4 split
Two Sigma Investments, LP0$00.00%−8,552−100.0%Sold outConverted for a 1-for-4 split
Two Sigma Advisers, LP0$00.00%−8,470−100.0%Sold outConverted for a 1-for-4 split
Point72 Asset Management, L.P.0$00.00%−6,834−100.0%Sold outConverted for a 1-for-4 split
State Street Corp0$00.00%−6,128−100.0%Sold outConverted for a 1-for-4 split
Kynam Capital Management, LP0$00.00%−6,009−100.0%Sold outConverted for a 1-for-4 split
Citadel Advisors LLC0$00.00%−5,490−100.0%Sold outConverted for a 1-for-4 split
Northern Trust Corp0$00.00%−3,432−100.0%Sold outConverted for a 1-for-4 split
Susquehanna International Group, LLP0$00.00%−3,289−100.0%Sold outConverted for a 1-for-4 split
Tower Research Capital LLC (TRC)0$00.00%−206−100.0%Sold outConverted for a 1-for-4 split